Pharmaceuticals

Gilenya Lawsuits

Gilenya (fingolimod) is used for the treatment of multiple sclerosis.  The U.S. Food and Drug Administration (FDA) initiated an investigation of Gilenya after reports that the medication is linked to heart attacks, stroke, and sudden death. New safety recommendations have been placed on labels for Gilenya as a result of the deaths of 15 patients.
 

Gilenya Lawyers are Ready to Help

Contact our Gilenya Lawyers to review whether you or a family member may be entitled to financial compensation. Levy Konigsberg LLP is currently accepting Gilenya cases in all 50 states.

If you or a loved one has suffered one or more of these complications, you may be entitled to a cash award and compensation for medical expenses. For a free confidential consultation with Gilenya Lawyers at our law firm, please call 1-800-988-8005 or submit an email inquiry above.
 

What is Gilenya?

Gilenya, which is manufactured by Novartis, is prescribed annually to nearly 30,000 people with relapsing multiple sclerosis.  Relapsing multiple sclerosis, which causes periodic flare-ups, is the most common form of the disease.  Multiple sclerosis is a disorder of the central nervous system that causes the immune system to attach the body’s myelin, the insulation that covers the nerves.  When the nerves suffer damage, they cannot properly transmit signals to the rest of the body.  This results in impairments in vision, muscle function, coordination, speech, and cognition in addition to muscle weakness, numbness and spasms.  Gilenya activates sensors in the lymph nodes to prevent blood cells from entering the blood stream and damaging the central nervous system.
 

What is Happening with Gilenya?

The FDA has advised that Gilenya may have serious side effects.  Gilenya has been shown to slow the patient’s heart rate, especially after the first dose.  A patient’s pulse and blood pressure must be monitored carefully for six hours upon initial dosing.  The FDA began a safety review of the medication in 2011 following the death of a 59 year old who died immediately after taking one dose of Gilenya.  Because patients are at risk for continued cardiac events, the FDA has warned that Gilenya should not be taken by patients with a history of heart attack, cardiovascular disease, stroke, or who already taking anti-arrhythmic drugs. There have been 15 deaths in total linked to Gilenya, several of which are attributed to cardiovascular events.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110865/

https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-severe-worsening-multiple-sclerosis-after-stopping-medicine-gilenya-fingolimod
 

Gilenya Side Effects and Complications

Common side effects of Gilenya include:

  • Headache;
  • Fatigue;
  • Flu symptoms;
  • Fever;
  • Difficulty breathing;
  • Chills;
  • Diarrhea; and
  • Back pain

Serious side effects of Gilenya include:

  • Chest pain;
  • Irregular heartbeat;
  • Heart attack;
  • Bradycardia and atrioventricular blocks;
  • Ischemic and hemorrhagic strokes; and
  • Sudden death

 

Gilenya Lawyers are Ready to Help

Contact our Gilenya Lawyers to review whether you or a family member may be entitled to financial compensation. Levy Konigsberg LLP is currently accepting Gilenya cases in all 50 states.

If you or a loved one has suffered one or more of these complications, you may be entitled to a cash award and compensation for medical expenses. For a free confidential consultation with Gilenya Lawyers at our law firm, please call 1-800-988-8005 or submit an email inquiry above.

For more information about the law firm's practice areas please contact Levy Konigsberg LLP at 1-212-605-6200 or 1-800-988-8005, 24 hours a day, 7 days a week.

Do You Have a Case?
Find Out Now.

National Offices

New York

800 Third Avenue, 11th Floor
New York, New York 10022
Telephone: 212-605-6200

New Jersey

101 Grovers Mill Rd, Ste 105
Lawrence Twp, NJ 08648
Telephone: 609-720-0400

Serving Clients Nationwide


Telephone: 800.988.8005

         
Google Rating
4.8
Based on 44 reviews
Attorney Advertising: Prior results do not guarantee a similar future outcome.